Kabra Drugs informs about board meeting

24 Jan 2019 Evaluate

Pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, Kabra Drugs has informed that the meeting of the Board of Directors of the company will be held on Friday, February 01, 2019, to consider the Un-Audited financial results of the company for quarter ending December 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

5.15 0.00 (0.00%)
19-Oct-2022 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 985.65
Cipla 1104.95
Dr. Reddys Lab 4357.50
Lupin 757.60
Zydus Lifesciences 407.25
View more..